Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial

This study has been completed.
Sponsor:
Collaborator:
Distrac
Information provided by:
University Ghent
ClinicalTrials.gov Identifier:
NCT00262444
First received: December 4, 2005
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Evaluation of the difference in pressure ulcer incidence or the time to develop pressure ulcers depending on the turning frequencies.


Condition Intervention
Pressure Ulcer Lesions (Grade 2 or More)
Procedure: Different turning frequencies

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial

Resource links provided by NLM:


Further study details as provided by University Ghent:

Primary Outcome Measures:
  • Incidence of pressure ulcers [ Time Frame: during 5 weeks ]
  • Time to develop pressure ulcers

Secondary Outcome Measures:
  • Different risk factors: age, length, weight, incontinence, urinary catheter, blood pressure, mobility, activity, diabetes, CVA, KATZ score, medication, duration in a sitting posture

Enrollment: 500
Study Start Date: September 2003
Study Completion Date: May 2005
Detailed Description:

Evaluation of the difference in pressure ulcer incidence or the time to develop pressure ulcers depending on the turning frequencies.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non-blanchable erythema above a bony prominence
  • Informed consent

Exclusion Criteria:

  • Pressure ulcers grade 3 or 4
  • Turning contra-indicated based on medical grounds
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00262444

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Ghent
Distrac
Investigators
Principal Investigator: Tom Defloor, PhD University Ghent
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00262444     History of Changes
Other Study ID Numbers: 2003/084
Study First Received: December 4, 2005
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Pressure Ulcer
Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer

ClinicalTrials.gov processed this record on November 27, 2014